Join our growing community to challenge mainstream media bias and fix the news
In new trial, Pfizer/BioNTech testing booster of Covid-19 vaccine

In new trial, Pfizer/BioNTech testing booster of Covid-19 vaccine

Pfizer/BioNTech said they are testing a third dose of their Covid-19 vaccine to have a better understanding of the immune response against new strains of the virus. Talking to media, Pfizer’s chief scientific officer, Mikael Dolsten said the mutation rate of the virus turned out to be higher than expected. He expressed confidence that current two-dose vaccine will work against new variants.

KCooper
KCooper
chris
chris 1 months

Gotta take the first one first.

Top in World